VCS

Tokyo Innovation Base: Tokyo's Node in the Global Startup Ecosystem, Opening May 2024

Retrieved on: 
Wednesday, March 13, 2024
Culture, Organization, Growth, University, Social media, Entrepreneurship, TIB, Exhibition, Ecosystem, VCS, Government, Legislation, Video game

TOKYO, Mar 14, 2024 - (ACN Newswire) - The Tokyo Metropolitan Government is proud to announce the launch of Tokyo Innovation Base.

Key Points: 
  • TOKYO, Mar 14, 2024 - (ACN Newswire) - The Tokyo Metropolitan Government is proud to announce the launch of Tokyo Innovation Base.
  • Combining the facilities of the startup campus and business networking hub in the beating heart of Japanese commerce and culture, Tokyo Innovation Base (TIB) seeks to supercharge the local startup scene and position Tokyo as a premier global hub for innovation and entrepreneurship.
  • Koike Yuriko, Governor of Tokyo, expressed her vision for Tokyo Innovation Base: "Our core values at TIB are global, growth, collaboration, and connect.
  • Don't take our word for it: Tokyo Innovation Base is having its grand opening in May, and it's open to all.

NeuroVigil, World’s Most Valuable Neurotech, Launches iBrain™ in US

Retrieved on: 
Friday, April 5, 2024
Head, Roche, MIT Technology Review, IP, FCCP, Clinic, Seed, Consciousness, Partnership, Novartis, SAN, DNA, Aneurysm, Critical care, Stanford School, Cedars-Sinai Medical Center, Lawyer, Harvard Medical School, DSS, University, MD, Hospital, FDA, Apnea, Brain, ALS, MIT, Neocortex, Biomarker, Bird, Doctor of Philosophy, Human, Brain tumor, BCIS, Silicon, Patent, VCS, Division

The investigators will initially not be allowed to modify anyone’s therapy based on iBrain data.

Key Points: 
  • The investigators will initially not be allowed to modify anyone’s therapy based on iBrain data.
  • A joint abstract by Dr. Low and Dr. Hawking featuring Dr. Hawking’s brain patterns analyzed by NeuroVigil’s technology was released as early as 2012.
  • The technology was also successfully demonstrated on ALS sufferer Augie Nieto in 2013 who spelled “COMMUNICATE” with his mind.
  • In the past two years, NeuroVigil has recruited talent from Amgen, Roche, Novartis and MIT in preparation for the launch.

CORRECTION -- NeuroVigil, World’s Most Valuable Neurotech Company, Launches in US

Retrieved on: 
Friday, April 5, 2024
Head, Roche, MIT Technology Review, IP, FCCP, Clinic, Seed, Consciousness, Partnership, Novartis, SAN, DNA, Aneurysm, Critical care, Stanford School, Cedars-Sinai Medical Center, Lawyer, Harvard Medical School, DSS, University, MD, Hospital, FDA, Apnea, Brain, ALS, MIT, Neocortex, Biomarker, Bird, Doctor of Philosophy, Human, Brain tumor, BCIS, Patent, VCS, Division

“Who needs implants when you have the real deal?” said Dr. Philip Low, PhD, NeuroVigil’s Chairman, Chief Executive and Technology Officer, Founder and Supermajority Owner.

Key Points: 
  • “Who needs implants when you have the real deal?” said Dr. Philip Low, PhD, NeuroVigil’s Chairman, Chief Executive and Technology Officer, Founder and Supermajority Owner.
  • The investigators will initially not be allowed to modify anyone’s therapy based on iBrain data.
  • The technology was also successfully demonstrated on ALS sufferer Augie Nieto in 2013 who spelled “COMMUNICATE” with his mind.
  • In the past two years, NeuroVigil has recruited talent from Amgen, Roche, Novartis and MIT in preparation for the launch.

NeuroVigil, World’s Most Valuable Neurotech Company, Launches in US

Retrieved on: 
Friday, April 5, 2024
Head, Roche, MIT Technology Review, IP, FCCP, Clinic, Seed, Consciousness, Partnership, Novartis, SAN, DNA, Aneurysm, Critical care, Stanford School, Cedars-Sinai Medical Center, Lawyer, Harvard Medical School, DSS, University, MD, Hospital, FDA, Apnea, Brain, ALS, MIT, Neocortex, Biomarker, Bird, Doctor of Philosophy, Human, Brain tumor, BCIS, Silicon, Patent, VCS, Division

The investigators will initially not be allowed to modify anyone’s therapy based on iBrain data.

Key Points: 
  • The investigators will initially not be allowed to modify anyone’s therapy based on iBrain data.
  • A joint abstract by Dr. Low and Dr. Hawking featuring Dr. Hawking’s brain patterns analyzed by NeuroVigil’s technology was released as early as 2012.
  • The technology was also successfully demonstrated on ALS sufferer Augie Nieto in 2013 who spelled “COMMUNICATE” with his mind.
  • In the past two years, NeuroVigil has recruited talent from Amgen, Roche, Novartis and MIT in preparation for the launch.

Token2049 Dubai Gears Up for Unmissable Social Event Hosted by Tobi and Brent

Retrieved on: 
Friday, April 5, 2024
Friends, Lock, Faculty, Kaisar, LP record, VCS, Work, Telegraphy, Cryptocurrency

Dubai UAE, April 05, 2024 (GLOBE NEWSWIRE) --  In true degen fashion, two friends have gathered the biggest organic group of the crypto community in the lead-up to Token2049 Dubai. Eponymously named “Token2049 Dubai with Tobi and Brent,” the Telegram group has rapidly grown to over 3000 members since its inception on March 13, 2024.

Key Points: 
  • Eponymously named “Token2049 Dubai with Tobi and Brent,” the Telegram group has rapidly grown to over 3000 members since its inception on March 13, 2024.
  • Known for their brutal anti-shilling approach, Tobi and Brent are taking steps to ensure the community spirit and mutual benefit of the group.
  • These self-proclaimed ‘bros’ are also set to host the biggest social side event of Token2049 Dubai.
  • I’ve created niche crypto communities in Singapore, Hong Kong, Bangkok, Denver, and NYC, and now we’re taking Dubai by storm.” commented Tobias Bauer (Tobi).

Informa PLC Confirms Dates for FinovateSpring 2024

Retrieved on: 
Wednesday, April 3, 2024
Fireside chats, Informa, Environment, Education, SAN, Time management, Calendar, Collection, VCS, Innovation, Management

SAN FRANCISCO, April 03, 2024 (GLOBE NEWSWIRE) -- via NetworkWire -- Informa PLC (“ Informa ”), a London-based events production, digital products and academic research services agency, is pleased to announce that FinovateSpring , a cutting-edge fintech conference catering to the digital future of financial institutions, will be held in person from May 21-23, 2024, at the Marriot Marquis San Francisco.

Key Points: 
  • SAN FRANCISCO, April 03, 2024 (GLOBE NEWSWIRE) -- via NetworkWire -- Informa PLC (“ Informa ”), a London-based events production, digital products and academic research services agency, is pleased to announce that FinovateSpring , a cutting-edge fintech conference catering to the digital future of financial institutions, will be held in person from May 21-23, 2024, at the Marriot Marquis San Francisco.
  • The highly anticipated event will demonstrate and advance the full scope of the fintech ecosystem, all under one roof.
  • At FinovateSpring, you are assured of impactful meetings with savvy, seasoned professionals and founders.
  • Moreover, if you're a director/head/SVP/C-level from a bank, insurer or investor (which includes asset/investment managers and family offices), you can attend FinovateSpring for free via the Finovate Leadership Program.

New AI research helps VCs vet ideas 10x faster

Retrieved on: 
Wednesday, March 27, 2024
Research, Risk, University, SAN, Internet, Artificial intelligence, Investment, Decision, GPT, VCS, University of Oxford, Cryptocurrency

Vela Research is the research arm of Vela Partners , the world’s first AI-native and product-led venture capitalist (VC) firm.

Key Points: 
  • Vela Research is the research arm of Vela Partners , the world’s first AI-native and product-led venture capitalist (VC) firm.
  • The research paper entitled Decision GPT: A Framework to Make Critical Decisions is designed to transform how VCs make investment decisions.
  • This helps millions of companies to be analyzed by an investor at human-level reasoning and efficiently scales decision making.
  • The use-case explored in the research paper is the evaluation of startups based on startup founders and their ideas.

Berkeley SkyDeck to Spotlight AI Innovation During Upcoming Demo Day

Retrieved on: 
Thursday, April 4, 2024
Professional Services, Education, Technology, Start-Up, Artificial Intelligence, University, Health, Patient, Entrepreneurship, Investment, Bridgestone, Zellerbach Hall, Berkeley SkyDeck, NVIDIA, VCS

Berkeley SkyDeck , the global hub for entrepreneurship and a leading accelerator, today confirmed its Demo Day for Batch 17 will take place April 10, 2024.

Key Points: 
  • Berkeley SkyDeck , the global hub for entrepreneurship and a leading accelerator, today confirmed its Demo Day for Batch 17 will take place April 10, 2024.
  • At the same time, investors are looking for companies capable of real success,” said Chon Tang, Founding Partner at Berkeley SkyDeck Fund.
  • Another SkyDeck alumnus focusing on AI mobile perception, Hayden AI , has raised over $100M in total, with investors including Mitsubishi Electric Innovation Fund and Bridgestone Corporation.
  • We look forward to seeing how our network of investors respond to this round of startups.”
    The Berkeley SkyDeck Demo Day will be hosted at Zellerbach Hall in Berkeley, California at 3pm PDT on April 10, 2024.

Allurion Expands Virtual Care Suite to the United States

Retrieved on: 
Thursday, April 4, 2024
Women, Other Health, Other Technology, Men, Telemedicine, Virtual Medicine, Family, Medical Devices, Hospitals, Consumer, Fitness & Nutrition, Technology, General Health, Biotechnology, Diabetes, Surgery, Health, Apps, Applications, Health Technology, Bariatric surgery, Conference, Obesity, VCS, Patient, Research, Artificial intelligence, Digital health, Digital, NPS, Satellite navigation device

Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the commercial availability of its comprehensive Virtual Care Suite (VCS) in the United States.

Key Points: 
  • Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the commercial availability of its comprehensive Virtual Care Suite (VCS) in the United States.
  • In 2023, Allurion added Coach Iris, a 24/7 AI-powered weight loss coach, to the VCS, enabling automated, conversational coaching and a more personalized behavior change program tailored to patient needs.
  • “After witnessing the profound impact our technology has had globally, we are thrilled to launch the VCS in the United States.
  • As part of the launch, Allurion will also be unveiling a new version of Allurion Insights, the web-based dashboard that providers use to navigate the VCS.

NMG Provides Commercial and Operational Update upon Filing 2023 Financial Reports: Significant Progress over the Year in Advancing North America’s Mine-to-Battery-Material Graphite Production

Retrieved on: 
Thursday, March 28, 2024
Natural Resources, Batteries, Alternative Energy, EV, Electric Vehicles, Energy, Automotive, Technology, Mining, Minerals, Carbon, Quality control, Anchor, Innu, Investment, TYO, Inflation, General Motors, EVS, Minority, FID, Education, Benchmark Mineral Intelligence, United States Geological Survey, Graphite, CO2, Verified Carbon Standard, Safety, Workforce, Climate change, Acceleration, VCS, GHG, ESG, Regulation, Acquisition, Student, Annual report, Kilowatt-hour, NOU, NMG, Engineering, Health, Intel, Government, Abitibi, GM, Pressure, Growth, Unitary state, Environment, Bloomberg, Mineral, Multimedia

Leveraging this technological platform, over 4,200 samples were reviewed and prepared by the Company’s battery laboratory in 2023.

Key Points: 
  • Leveraging this technological platform, over 4,200 samples were reviewed and prepared by the Company’s battery laboratory in 2023.
  • NMG also signed a supply agreement with GM for 18,000 tpa of active anode material for an initial term of six years.
  • The Company maintains intensive commercial discussions and continued product qualification with other tier-1 battery manufacturers for the balance of its Phase-2 production.
  • Such measures reaffirm the importance of establishing a local, resilient, and ESG-compliant supply chain of graphite to support battery and EV production.